MediciNova Inc (MNOV)

2.470
+0.080(+3.35%)
After Hours
2.350
-0.120(-4.858%)
- Real-time Data
  • Volume:
    59,646
  • Day's Range:
    2.410 - 2.578
  • 52 wk Range:
    2.090 - 5.090

MNOV Overview

Prev. Close
2.39
Day's Range
2.41-2.578
Revenue
4.04M
Open
2.41
52 wk Range
2.09-5.09
EPS
-0.21
Volume
59,646
Market Cap
123.11M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
46,475
P/E Ratio
-
Beta
1.17
1-Year Change
-40.05%
Shares Outstanding
49,046,246
Next Earnings Date
Jul 27, 2022
What is your sentiment on MediciNova?
or
Market is currently closed. Voting is open during market hours.

MediciNova Inc News

MediciNova Inc Analysis

  • Here's What Happened With MediciNova
    • BySamuel Rae-

    MediciNova Inc. (NASDAQ:MNOV) is having a good week. The company just put out data from a phase II trial of one of its lead development assets and – as per the release...

MediciNova Inc Company Profile

MediciNova Inc Company Profile

Employees
11

MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) and MN-001 (tipelukast). Its ibudilast is for neurological and other disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction, and prevention of acute respiratory distress syndrome. Its tipelukast is for fibrotic diseases, such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The Company's pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers. Its ibudilast is in development for various neurological diseases and other diseases.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellSellStrong Sell
Technical IndicatorsSellStrong SellStrong BuyNeutralStrong Sell
SummaryNeutralSellNeutralNeutralStrong Sell
  • why has this gone back down after such a nice rise?
    0
    • I know. just wait.
      0
      • Ya’ll going to be really disappointed with this penny stock.
        0
        • I'm liking this stock.
          0